Iratumumab: Difference between revisions
m Protected "Iratumumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 32: | Line 32: | ||
{{Humanmonoclonals}} | {{Humanmonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 16:33, 9 August 2012
WikiDoc Resources for Iratumumab |
Articles |
---|
Most recent articles on Iratumumab |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Iratumumab at Clinical Trials.gov Clinical Trials on Iratumumab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Iratumumab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Iratumumab Discussion groups on Iratumumab Patient Handouts on Iratumumab Directions to Hospitals Treating Iratumumab Risk calculators and risk factors for Iratumumab
|
Healthcare Provider Resources |
Causes & Risk Factors for Iratumumab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Iratumumab is a human monoclonal antibody which is used to treat cancer.
Template:Humanmonoclonals Template:WH Template:WikiDoc Sources